Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo

Journal of Virology

Volumn 81, Issue 2, 2007, Pages 639-649

  Pan, Yung Wei ^a   Scarlett, Jarrad M ^a   Luoh, Tammy T ^a   Kurre, Peter ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; MEMBRANE PROTEIN; VIRUS VECTOR;

ARTICLE; BIOSAFETY; COCULTURE; COMPLEMENT INHIBITION; EX VIVO STUDY; GENE EXPRESSION; GENETIC TRANSDUCTION; GERM LINE; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBIAL ADHESION; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; TRANSGENE; VESICULAR STOMATITIS VIRUS; VIRUS ADSORPTION; VIRUS PARTICLE;

ANIMALS; CELL ADHESION; CELL LINE; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HIV-1; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NIH 3T3 CELLS; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE; VESICULAR STOMATITIS VIRUS;

EID: 33846103848     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01089-06     Document Type: Article

References (41)

1. Ailles, L., M. Schmidt, F. R. Santoni de Sio, H. Glimm, S. Cavalieri, S. Bruno, W. Piacibello, C. Von Kalle, and L. Naldini. 2002. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells. Mol. Ther. 6:615-626.
2. Anjos-Afonso, F., E. K. Siapati, and D. Bonnet. 2004. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell Sci. 117:5655-5664.
3. Bell, P., L. J. Montaner, and G. G. Maul. 2001. Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA. J. Virol. 75:7683-7691.
4. Bigger, B. W., E. K. Siapati, A. Mistry, S. N. Waddington, M. S. Nivsarkar, L. Jacobs, R. Perrett, M. V. Holder, C. Ridler, G. Kemball-Cook, R. R. Ali, S. J. Forbes, C. Coutelle, N. Wright, M. Alison, A. J. Thrasher, D. Bonnet, and M. Themis. 2006. Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX. Gene Ther. 13:117-126.
5. Blomer, U., I. Gruh, H. Witschel, A. Haverich, and U. Martin. 2005. Shuttle of lentiviral vectors via transplanted cells in vivo. Gene Ther. 12:67-74.
6. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
7. Carbonaro, D. A., X. Jin, D. Petersen, X. Wang, F. Dorey, K. S. Kil, M. Aldrich, M. R. Blackburn, R. E. Kellems, and D. B. Kohn. 2006. In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency. Mol. Ther. 13:1110-1120.
8. Case, S. S., M. A. Price, C. T. Jordan, X. J. Yu, L. Wang, G. Bauer, D. L. Haas, D. Xu, R. Stripecke, L. Naldini, D. B. Kohn, and G. M. Crooks. 1999. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl. Acad. Sci. USA 96:2988-2993.
9. Coil, D. A., and A. D. Miller. 2004. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J. Virol. 78:10920-10926.
10. Cole, C., J. Qiao, T. Kottke, R. M. Diaz, A. Ahmed, L. Sanchez-Perez, G. Brunn, J. Thompson, J. Chester, and R. G. Vile. 2005. Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells. Nat. Med. 11:1073-1081.
11. Cosset, F. L., Y. Takeuchi, J. L. Battini, R. A. Weiss, and M. K. Collins. 1995. High-liter packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
12. DePolo, N. J., J. D. Reed, P. L. Sheridan, K. Townsend, S. L. Sauter, D. J. Jolly, and T. W. Dubensky, Jr. 2000. VSV-G pseudotyped lentivital vector particles produced in human cells are inactivated by human serum. Mol. Ther. 2:218-222.
13. Follenzi, A., G. Sabatino, A. Lombardo, C. Boccaccio, and L. Naldini. 2002. Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum. Gene Ther. 13:243-260.
14. Haas, D. L., S. S. Case, G. M. Crooks, and D. B. Kohn. 2000. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2:71-80.
15. Higashikawa, F., and L. Chang. 2001. Kinetic analyses of stability of simple and complex retroviral vectors. Virology 280:124-131.
16. Imren, S., M. E. Fabry, K. A. Westerman, R. Pawliuk, P. Tang, P. M. Rosten, R. L. Nagel, P. Leboulch, C. J. Eaves, and R. K. Humphries. 2004. High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells. J. Clin. Investig. 114:953-962.
17. Kang, E., N. Giri, T. Wu, S. Sellers, M. Kirby, Y. Hanazono, J. Tisdale, and C. E. Dunbar. 2001. In vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myeloablated setting. Hum. Gene Ther. 12:1663-1672.
18. Kurre, P., P. Anandakumar, M. A. Harkey, B. Thomasson, and H. P. Kiem. 2004. Efficient marking of murine long-term repopulating stem cells targeting unseparated marrow cells at low lentiviral vector particle concentration. Mol. Ther. 9:914-922.
19. Larochelle, A., and C. E. Dunbar. 2004. Genetic manipulation of hematopoietic stem cells. Semin. Hematol. 41:257-271.
20. Levasseur, D. N., T. M. Ryan, K. M. Pawlik, and T. M. Townes. 2003. Correction of a mouse model of sickle cell disease: lentiviral/ antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells. Blood 102:4312-4319.
21. Mazurier, F., O. I. Gan, J. L. McKenzie, M. Doedens, and J. E. Dick. 2004. Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 103:545-552.
22. Mikkola, H., N. B. Woods, M. Sjogren, H. Helgadottir, I. Hamaguchi, S. E. Jacobsen, D. Trono, and S. Karlsson. 2000. Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells. J. Virol. 74:11911-11918.
23. Miyoshi, H., M. Takahashi, F. H. Gage, and I. M. Verma. 1997. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA 94:10319-10323.
24. Mostoslavskv, G., D. N. Kotton, A. J. Fabian, J. T. Gray, J.-S. Lee, and R. C. Mulligan. 2005. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal manipulation. Mol. Ther. 11:932-940.
25. Overbaugh, J., A. D. Miller, and M. V. Eiden. 2001. Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol. Mol. Biol. Rev. 65:371-389.
26. Pan, D., R. Gunther, W. Duan, S. Wendell, W. Kaemmerer, T. Kafri, I. M. Verma, and C. B. Whitley. 2002. Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Mol. Ther. 6:19-29.
27. Park, F., K. Ohashi, W. Chiu, L., Naldini, and M. A. Kay. 2000. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24:49-52.
28. Peng, K. W., L. Pham, H. Ye, R. Zufferey, D. Trono, F. L. Cosset, and S. J. Russell. 2001. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 8:1456-1463.
29. Persons, D. A., and J. F. Tisdale. 2004. Gene therapy for the hemoglobin disorders. Semin. Hematol. 41:279-286.
30. Pizzato, M., E. D. Blair, M. Fling, J. Kopf, A. Tomassetti, R. A. Weiss, and Y. Takeuchi. 2001. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. Gene Ther. 8:1088-1096.
31. Pizzato, M., S. A. Marlow, E. D. Blair, and Y. Takeuchi. 1999. Initial binding of murine leukemia virus particles to cells does not require specific Envreceptor interaction. J. Virol. 73:8599-8611.
32. Rosenzweig, M., M. Connole, R. Glickman, S. P. Yue, B. Noren, M. DeMaria, and R. P. Johnson. 2001. Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood 97:1951-1959.
33. Sandrin, V., B. Boson, P. Salmon, W. Gay, D. Negre, R. Le Grand, D. Trono, and F. L. Cosset. 2002. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 100:823-832.
34. Sastry, L., Y. Xu, T. Johnson, K. Desai, D. Rissing, J. Marsh, and K. Cornetta. 2003. Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Mol. Ther. 8:830-839.
35. Schlegel, R., M. C. Willingham, and I. H. Pastan. 1982. Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells. J. Virol. 43:871-875.
36. Sharma, S., A. Miyanohara, and T. Friedmann. 2000. Separable mechanisms of attachment and cell uptake during retrovirus infection. J. Virol. 74:10790-10795.
37. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
38. Takeuchi, Y., F. L. Cosset, P. J. Lachmann, H. Okada, R. A. Weiss, and M. K. Collins. 1994. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68: 8001-8007.
39. 1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95:11939-11944.
40. Verhoeyen, E., and F. L. Cosset. 2004. Surface-engineering of lentiviral vectors. J. Gene Med. 6(Suppl. 1):S83-S94.
41. Verhoeyen, E., M. Wiznerowicz, D. Olivier, B. Izac, D. Trono, A. Dubart-Kupperschmitt, and F. L. Cossel. 2005. Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells. Blood 106:3386-3395.